City

Kampala (1)

Condition

Transgender Men (2)

Blood Pressure (1)

HIV (1)

Hyperandrogenism (1)

PrEP (1)

Sexually Transmitted Infections (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

n/a (1)

Sponsor

Makerere University (1)

Yale University (1)

Collaborator

Massachusetts General Hospital (1)

The John B. Pierce Laboratory (1)

Intervention

lamivudine-tenofovir 300 mg-300 mg oral tablet (1)

trans men (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

transgender men

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Transgender Men, Blood Pressure, Hyperandrogenism Trial (Trans men)

Not yet recruiting

Transgender Men
+2 more

Trans men

(no location specified)

Feb 9, 2022

Transgender Men and HIV in Uganda: PrEP Uptake and Persistence

Recruiting

HIV
+3 more

Lamivudine-Tenofovir 300 Mg-300 Mg Oral Tablet

Kampala, Uganda

Infectious Diseases Institute Kasangati

Dec 2, 2021